Altamira Therapeutics : Warrant Inducement Agreement - Form 6-K -December 08, 2023 at 09:02 am EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
Page 10 - Thomas Meyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Meyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Meyer Today - Breaking & Trending Today
An Austrian Castle With Connections to Mozart Is Up for Auction     – Robb Report
Mozart's last score, “Requiem in D minor" was begun while the composer stayed at Schloss Stuppach in Gloggnitz, Austria, in 1791, the year he died.
Source: robbreport.com
Altamira Therapeutics : Compliance with Continued Listing Rule - Form 6-K -November 22, 2023 at 04:36 pm EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
Initiates Strategic Repositioning to Focus on Company’s Core RNA Delivery Technology Altamira Therapeutics retains 49% in Altamira Medica AG, and secures 25% of future licensing revenue ...
Source: marketscreener.com
Why Is Allergy-Focused Altamira Therapeutics (CYTO) Stock Trading Over 200% Higher Today? - Altamira Therapeutics (NASDAQ:CYTO)
Altamira Therapeutics Ltd (NASDAQ: CYTO) entered into a binding agreement to sell a 51% stake in its subsidiary Altamira Medica AG to a Swiss private equity investor as part of its strategic repositioning around
Source: benzinga.com